{"transactions":[{"id":3364552,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":153680,"kind":"person","name":"Masuda Esteban","position":1,"cik":"0001686849","reported_name":"Masuda Esteban","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-21T01:18:03.000Z","date":"2019-11-18","kind":"sale","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person was granted a performance based option to purchase 62,500 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted a performance based option to purchase 62,500 shares of common stock on January 24, 2018. Thus, the exercise price of this option is $4.49 (the closing price of the issuer's common stock on Nasdaq the day prior to the date of grant). In light of the performance-based vesting condition of this grant, this grant was not reportable under Section 16 until the performance metric was satisfied. On November 18, 2019, it was determined that the performance metric had been met.."}],"balance_after":62500,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001179110-19-011944","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019011944/edgar.xml","form_type":"4"}},{"id":3581869,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":153680,"kind":"person","name":"Masuda Esteban","position":1,"cik":"0001686849","reported_name":"Masuda Esteban","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-22T23:24:07.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 24, 2018, the reporting person was granted a performance based option to purchase 62,500 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met."}],"balance_after":62500,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001179110-19-004209","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019004209/edgar.xml","form_type":"4"}},{"id":3686939,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":153680,"kind":"person","name":"Masuda Esteban","position":1,"cik":"0001686849","reported_name":"Masuda Esteban","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-25T23:51:47.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019."}],"balance_after":100000,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-19-000938","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019000938/edgar.xml","form_type":"4"}},{"id":3937328,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":153680,"kind":"person","name":"Masuda Esteban","position":1,"cik":"0001686849","reported_name":"Masuda Esteban","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Research"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-11T23:50:16.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 2, 2017 the reporting person was granted an option to purchase 50,000 shares of common stock.  The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved.  On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option."}],"balance_after":50000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-18-006681","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018006681/edgar.xml","form_type":"4"}},{"id":4088433,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":153680,"kind":"person","name":"Masuda Esteban","position":1,"cik":"0001686849","reported_name":"Masuda Esteban","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-26T23:35:23.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018."}],"balance_after":125000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-18-001144","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018001144/edgar.xml","form_type":"4"}},{"id":4466631,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":153680,"kind":"person","name":"Masuda Esteban","position":1,"cik":"0001686849","reported_name":"Masuda Esteban","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP Research"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T00:30:51.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest monthly over four (4) years from January 1, 2017."}],"balance_after":50000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-17-001827","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017001827/edgar.xml","form_type":"4"}}]}